CATALOGO DEI PRODOTTI DELLA RICERCA

Granata, Simona
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.946
EU - Europa 1.747
AS - Asia 1.191
SA - Sud America 185
AF - Africa 19
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 5.094
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.922
GB - Regno Unito 552
CN - Cina 472
SG - Singapore 411
IT - Italia 252
SE - Svezia 207
FR - Francia 166
BR - Brasile 160
IE - Irlanda 137
RU - Federazione Russa 124
DE - Germania 121
HK - Hong Kong 121
FI - Finlandia 87
VN - Vietnam 74
ID - Indonesia 26
UA - Ucraina 24
BE - Belgio 18
AT - Austria 17
KR - Corea 16
AR - Argentina 13
IN - India 13
TR - Turchia 13
CA - Canada 9
JP - Giappone 8
MX - Messico 8
PL - Polonia 6
RO - Romania 6
ZA - Sudafrica 6
EC - Ecuador 5
ES - Italia 5
NL - Olanda 5
MY - Malesia 4
UZ - Uzbekistan 4
AU - Australia 3
CH - Svizzera 3
DK - Danimarca 3
EU - Europa 3
GR - Grecia 3
IL - Israele 3
KG - Kirghizistan 3
PK - Pakistan 3
AZ - Azerbaigian 2
BH - Bahrain 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
IQ - Iraq 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
MA - Marocco 2
PY - Paraguay 2
TT - Trinidad e Tobago 2
AD - Andorra 1
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BD - Bangladesh 1
BO - Bolivia 1
CG - Congo 1
CM - Camerun 1
CO - Colombia 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MU - Mauritius 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
RS - Serbia 1
SA - Arabia Saudita 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 5.094
Salva come PNG Salva come JPEG
Città #
Southend 487
Chandler 359
Singapore 195
Jacksonville 155
Dallas 152
Dublin 133
Ashburn 120
Hong Kong 120
Ann Arbor 108
Woodbridge 96
Beijing 90
Wilmington 55
Lawrence 50
Princeton 50
Houston 43
New York 41
Dong Ket 40
Verona 38
Jinan 36
Redmond 36
Columbus 31
Nanjing 28
Shenyang 27
The Dalles 24
Seattle 23
Helsinki 21
Council Bluffs 20
Hebei 20
Jakarta 18
Brussels 17
Kent 17
Munich 17
Sindelfingen 17
São Paulo 16
Boardman 15
Ningbo 15
Lancaster 14
Tianjin 14
Los Angeles 13
Rome 13
Taizhou 13
Vienna 13
Changsha 12
Padova 11
Zhengzhou 11
Jiaxing 10
Santa Clara 10
Nanchang 9
Auburn Hills 8
Haikou 8
Hangzhou 8
Milan 8
Redwood City 8
San Francisco 8
Tokyo 8
Guangzhou 7
Moscow 7
Nuremberg 7
Porto Alegre 7
Rio de Janeiro 7
Taiyuan 7
Turku 7
Chicago 6
London 6
Redondo Beach 6
Seoul 6
Venice 6
Washington 6
Bologna 5
Boston 5
Fuzhou 5
Lanzhou 5
Norwalk 5
Phoenix 5
Turin 5
Atlanta 4
Brooklyn 4
Cambridge 4
Denver 4
Esslingen am Neckar 4
Foggia 4
Frankfurt am Main 4
Genova 4
Kochi 4
Mexico City 4
Ankara 3
Bishkek 3
Brasília 3
Buffalo 3
Dongguan 3
Fairfield 3
Florence 3
Ho Chi Minh City 3
Johannesburg 3
Manchester 3
Novokuznetsk 3
Parma 3
Shijiazhuang 3
Tel Aviv 3
Toronto 3
Totale 3.134
Salva come PNG Salva come JPEG
Nome #
Eparanasi: un nuovo biomarker di fibrosi e un potenziale target farmacologico per ridurre la progressione del danno renale cronico 193
DISREGOLAZIONE DELLA BIOSINTESI E DEL METABOLISMO DEI PROTEOGLICANI/GLICOSAMINOGLICANI NEI SOGGETTI UREMICI: UNO STUDIO DI GENOMICA FUNZIONALE 191
IDENTIFICATION OF MOLECULAR BIOMARKERS FOR EARLY DIAGNOSIS OF DELAYED GRAFT FUNCTION IN RENAL TRANSPLANT RECIPIENTS 146
A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients. 131
In Vitro Identification of New Transcriptomic and miRNomic Profiles Associated with Pulmonary Fibrosis Induced by High Doses Everolimus: Looking for New Pathogenetic Markers and Therapeutic Targets. 130
mTOR inhibitors and renal allograft: Yin and Yang. 128
Monoclonal antibody therapy and renal transplantation: focus on adverse effects. 125
Comparative transcriptome analysis of peripheral blood mononuclear cells in renal transplant recipients in everolimus- and tacrolimus-based immunosuppressive therapy 125
Proteomic-based research strategy identified laminin subunit alpha 2 as a potential urinary-specific biomarker for the medullary sponge kidney disease. 124
NLRP3 Inflammasome Activation in Dialyzed Chronic Kidney Disease Patients. 122
IDENTIFICAZIONE DI BIOMARCATORI MOLECOLARI PER LA DIAGNOSI PRECOCE DELLA FUNZIONALITÀ RITARDATA DELL'ORGANO TRAPIANTATO 120
Sirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular Effects 119
DISTURBI PSICOLOGICI, QUALITÀ DI VITA E PRODUZIONE DI CITOCHINE NEI PAZIENTI IN EMODIALISI 118
Downregulation of nuclear-encoded genes of oxidative metabolism in dialyzed chronic kidney disease patients. 118
Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition. 118
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation 118
Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: Comparison between an everolimus- and a standard tacrolimus-based regimen. 116
Emotional symptoms, quality of life and cytokine profile in hemodialysis patients. 115
How has peritoneal dialysis changed over the last 30 years: experience of the Verona dialysis center 114
Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase. 112
Dialysis-related systemic microinflammation is associated with specific genomic patterns 111
Extra-renal adverse effects of mTOR inhibitors: know them to optimize their use in renal transplantation. 110
Karyopherins: potential biological elements involved in the delayed graft function in renal transplant recipients. 107
Personalization of the Immunosuppressive Treatment in Renal Transplant Recipients: The Great Challenge in "Omics" Medicine. 105
Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney Disease. 105
Systemic and Nonrenal Adverse Effects Occurring in Renal Transplant Patients Treated with mTOR Inhibitors. 104
Sphingomyelin and medullary sponge kidney disease: a biological link identified by omics approach 103
Proteomic Analysis of Urinary Microvesicles and Exosomes in Medullary Sponge Kidney Disease and Autosomal Dominant Polycystic Kidney Disease. 100
Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury 98
Mitochondria: a new therapeutic target in chronic kidney disease. 97
Dialysis-related transcriptomic profiling: The pivotal role of heparanase. 96
Pharmacogenetics: a promising tool to personalize immunosuppressive therapy in renal transplantation. 96
Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells. 95
From pharmacogenetics to pharmacogenomics: the birth of a new era of personalized medicine in nephrology 93
Sclerostin and Dickkopf-1 in post-menopausal renal allograft recipients. 93
mTOR Inhibition Role in Cellular Mechanisms 93
Naturally Occurring Compounds: New Potential Weapons against Oxidative Stress in Chronic Kidney Disease. 91
The Genetic Architecture of Membranous Nephropathy and Its Potential to Improve Non-Invasive Diagnosis 85
High-Dose Everolimus May Induce Pro-Inflammatory/Fibrotic Transcriptomic Changes in Bronchial Epithelial Cells from Cystic Fibrosis Patients 85
Analysis of urinary exosomes applications for rare kidney disorders. 82
Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease 80
Hypomethylation of NLRP3 gene promoter discriminates glucocorticoid-resistant from glucocorticoid-sensitive idiopathic nephrotic syndrome patients 80
Pharmacogenomics: a new paradigm to personalize treatments in nephrology patients. 77
Inhibition of heparanase protects against chronic kidney dysfunction following ischemia/reperfusion injury. 77
Proteomic Analysis of Urinary Extracellular Vesicles Reveals a Role for the Complement System in Medullary Sponge Kidney Disease 76
In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells. 74
PNPLA3 I148M gene variant and chronic kidney disease in type 2 diabetic patients with NAFLD: Clinical and experimental findings 70
Kidney Allograft Fibrosis: What We Learned From Latest Translational Research Studies 67
Recent Advances in the Role of Natural Killer Cells in Acute Kidney Injury 52
Proteomic profile of mesothelial exosomes isolated from peritoneal dialysis effluent of children with focal segmental glomerulosclerosis 45
Totale 5.230
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.548
article - articoli 17.818
book - libri 0
conference - conferenze 1.730
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.096
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021307 0 0 8 37 55 34 16 19 4 6 40 88
2021/2022399 25 76 11 67 8 17 28 31 12 9 25 90
2022/20231.002 62 140 83 172 85 228 8 51 119 6 32 16
2023/2024450 23 39 49 40 57 81 9 40 3 10 82 17
2024/20251.054 52 67 47 202 49 37 68 52 152 50 98 180
2025/2026469 225 136 108 0 0 0 0 0 0 0 0 0
Totale 5.230